MX337139B - Composicion de miel con l-alanil-l-glutamina. - Google Patents

Composicion de miel con l-alanil-l-glutamina.

Info

Publication number
MX337139B
MX337139B MX2013012967A MX2013012967A MX337139B MX 337139 B MX337139 B MX 337139B MX 2013012967 A MX2013012967 A MX 2013012967A MX 2013012967 A MX2013012967 A MX 2013012967A MX 337139 B MX337139 B MX 337139B
Authority
MX
Mexico
Prior art keywords
alanyl
glutamine
honey
honey composition
composition
Prior art date
Application number
MX2013012967A
Other languages
English (en)
Spanish (es)
Other versions
MX2013012967A (es
Inventor
Mike Mcinnes
Original Assignee
Benenox Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Benenox Ltd filed Critical Benenox Ltd
Publication of MX2013012967A publication Critical patent/MX2013012967A/es
Publication of MX337139B publication Critical patent/MX337139B/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/56—Materials from animals other than mammals
    • A61K35/63—Arthropods
    • A61K35/64—Insects, e.g. bees, wasps or fleas
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/05—Dipeptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/56—Materials from animals other than mammals
    • A61K35/63—Arthropods
    • A61K35/64—Insects, e.g. bees, wasps or fleas
    • A61K35/644—Beeswax; Propolis; Royal jelly; Honey
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Insects & Arthropods (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Animal Husbandry (AREA)
  • Zoology (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Anesthesiology (AREA)
  • Pulmonology (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Jellies, Jams, And Syrups (AREA)
  • Medicinal Preparation (AREA)
  • Seasonings (AREA)
MX2013012967A 2011-05-18 2012-05-16 Composicion de miel con l-alanil-l-glutamina. MX337139B (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB1108343.3A GB201108343D0 (en) 2011-05-18 2011-05-18 Honey composition
PCT/GB2012/051090 WO2012156731A1 (en) 2011-05-18 2012-05-16 Honey composition with l-alanyl- l- glutamine

Publications (2)

Publication Number Publication Date
MX2013012967A MX2013012967A (es) 2014-05-13
MX337139B true MX337139B (es) 2016-02-12

Family

ID=44260736

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2013012967A MX337139B (es) 2011-05-18 2012-05-16 Composicion de miel con l-alanil-l-glutamina.

Country Status (21)

Country Link
US (2) US10314879B2 (pt-PT)
EP (1) EP2709638B1 (pt-PT)
JP (2) JP6328552B2 (pt-PT)
KR (1) KR101900904B1 (pt-PT)
CN (2) CN103747791B (pt-PT)
AU (1) AU2012257566B2 (pt-PT)
CA (1) CA2834182C (pt-PT)
CY (1) CY1117053T1 (pt-PT)
DK (1) DK2709638T3 (pt-PT)
ES (1) ES2553655T3 (pt-PT)
GB (1) GB201108343D0 (pt-PT)
HK (1) HK1196097A1 (pt-PT)
HR (1) HRP20151320T1 (pt-PT)
HU (1) HUE028293T2 (pt-PT)
MX (1) MX337139B (pt-PT)
PL (1) PL2709638T3 (pt-PT)
PT (1) PT2709638E (pt-PT)
RS (1) RS54412B1 (pt-PT)
SI (1) SI2709638T1 (pt-PT)
SM (1) SMT201600056B (pt-PT)
WO (1) WO2012156731A1 (pt-PT)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB201108343D0 (en) * 2011-05-18 2011-06-29 Hibernation Honey Ltd Honey composition
WO2018026703A1 (en) * 2016-08-01 2018-02-08 Filament Biosolutions Inc. Methods of treating and preventing cancer treatment side effects
ES2908806T3 (es) * 2016-12-30 2022-05-04 Innobio Corporation Ltd Gen que codifica la enzima biosintética del dipéptido de alanil-glutamina y aplicación del mismo
CN113040393A (zh) * 2021-03-31 2021-06-29 杨继辉 一种干预焦虑睡眠障碍的营养配方

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2919059A1 (de) * 1979-05-10 1980-11-20 Josef Dipl Chem Dr Rer N Klosa Diaetetisches mittel und verfahren zu seiner herstellung
US4532143A (en) * 1984-06-15 1985-07-30 The J. M. Smucker Company Spreadable honey
US4973491A (en) * 1989-06-06 1990-11-27 Ontario Ministry Of Agriculture And Food Honey product
JP2829793B2 (ja) * 1991-01-10 1998-12-02 長谷川香料株式会社 飲食品の蜂蜜様風味改善方法
GB9121467D0 (en) * 1991-10-10 1991-11-27 Sandoz Nutrition Ltd Improvements in or relating to organic compounds
JP3473976B2 (ja) * 1992-10-29 2003-12-08 協和醗酵工業株式会社 アラニルグルタミンの製造法
CN1802152A (zh) * 2002-08-01 2006-07-12 艾斯根公司 用谷氨酰胺改善癌症的治疗
JP4595651B2 (ja) * 2005-04-25 2010-12-08 株式会社デンソー 生体センサ、睡眠情報処理方法、及び睡眠情報処理装置
KR20080064834A (ko) * 2005-10-12 2008-07-09 가부시키가이샤 오츠카 세이야쿠 고죠 저혈당증 억제용 조성물
CN101312660B (zh) * 2005-11-23 2013-07-17 可口可乐公司 供体重管理之高效甜味剂以及经彼甜化的组成物
WO2007119503A1 (ja) * 2006-03-23 2007-10-25 Kyowa Hakko Kogyo Co., Ltd. 寝起き改善剤
US9119416B2 (en) * 2006-03-23 2015-09-01 Kyowa Hakko Bio Co., Ltd. Muscle fatigue remedy
JP5046364B2 (ja) * 2006-09-15 2012-10-10 パナソニック株式会社 睡眠状況評価システム及びそのプログラム
CN101041008A (zh) * 2007-04-28 2007-09-26 王军 三冬丹
EP2177113A1 (en) * 2008-10-15 2010-04-21 Nestec S.A. Improved liver glycocen synthesis
JP2010260853A (ja) * 2009-04-08 2010-11-18 Kyowa Hakko Bio Co Ltd アラニルグルタミンを含有する造粒粉末、顆粒または錠剤
CN101999572A (zh) * 2010-11-08 2011-04-06 王福起 助眠蜜及制备方法
GB201108343D0 (en) * 2011-05-18 2011-06-29 Hibernation Honey Ltd Honey composition

Also Published As

Publication number Publication date
JP6328552B2 (ja) 2018-05-23
SI2709638T1 (sl) 2016-01-29
US20140186457A1 (en) 2014-07-03
DK2709638T3 (da) 2015-12-21
PL2709638T3 (pl) 2016-03-31
AU2012257566B2 (en) 2017-03-02
JP2017061488A (ja) 2017-03-30
AU2012257566A1 (en) 2013-11-14
CN103747791B (zh) 2018-01-30
CY1117053T1 (el) 2017-04-05
HUE028293T2 (en) 2016-12-28
JP2014513713A (ja) 2014-06-05
CA2834182C (en) 2021-05-18
PT2709638E (pt) 2016-01-07
KR20140058435A (ko) 2014-05-14
WO2012156731A1 (en) 2012-11-22
CA2834182A1 (en) 2012-11-22
CN108159391A (zh) 2018-06-15
RS54412B1 (en) 2016-04-28
GB201108343D0 (en) 2011-06-29
CN103747791A (zh) 2014-04-23
HK1196097A1 (en) 2014-12-05
ES2553655T3 (es) 2015-12-10
JP6336003B2 (ja) 2018-06-06
MX2013012967A (es) 2014-05-13
KR101900904B1 (ko) 2018-09-21
EP2709638A1 (en) 2014-03-26
HRP20151320T1 (hr) 2016-01-15
US10314879B2 (en) 2019-06-11
EP2709638B1 (en) 2015-09-30
US20190192612A1 (en) 2019-06-27
SMT201600056B (it) 2016-04-29

Similar Documents

Publication Publication Date Title
MX344238B (es) Compuestos de tetrazol y métodos para preparar y usar los mismos.
JO3199B1 (ar) مركبات 5- فلورو-1h- بيرازولوبيريدينات مستبدلة واستخدامها
MX365835B (es) Uso de akkermansia para tratar trastornos metabolicos.
IL231536A (en) Indazole-3-carboxamides, pharmaceuticals containing them and their use in the treatment of diseases
MX345535B (es) Compuestos tricíclicos parcialmente saturados y métodos para su fabricación y su uso.
MY156777A (en) Substituted 2-acetamido-5-ary1-1,2,4-triazolones and use thereof
MX343687B (es) Compuestos sulfonamida tricíclica y métodos para su fabricación y uso.
AU2011328009A8 (en) Compounds and methods for treating pain
MX2012011771A (es) Aptameros para beta-ngf y su uso en el tratamiento de enfermedades y trastornos mediados por beta-ngf.
MX343688B (es) Compuestos tricíclicos de sulfonamida y pirazolo y métodos para su fabricación y uso.
MX2013011908A (es) Composiciones y usos terapeuticos de inhibidores de cinasa epsilon relacionados con cinasa i-kappa b (ikk) y cinasa 1 de union tank.
NZ630805A (en) Pharmaceutical combinations comprising a thionucleotide analog
PL2731947T3 (pl) Podstawiona dimeryczna pochodna chinazoliny, sposób jej wytwarzania i jej zastosowanie w kompozycjach farmaceutycznych do leczenia cukrzycy typu I i II
MX2014008705A (es) Compuestos tricíclicos de sulfona y métodos para elaborarlos y utilizarlos.
IN2015DN03322A (pt-PT)
MX2014008706A (es) Compuestos tricíclicos de sulfonamida y métodos para elaborarlos y usarlos.
MX366368B (es) Metodos para el cuidado oral prebiotico usando un sacarido.
TN2014000046A1 (en) Substituted 3-(biphenyl-3-yl)-4-hydroxy-8-methoxy-1-azaspiro[4.5]dec-3-en-2-one
MX2013013649A (es) Compuestos de quinona para tratar enfermedades mediadas por ape1.
MY150931A (en) Substituted oxazolidinones and their use
MX2015005732A (es) Compuestos tricíclicos y métodos para hacer y utilizar los mismos.
MY171048A (en) Pharmaceutical composition for preventing or treating amyloid beta peptide-associated diseases or conditions
MX2013012967A (es) Composicion de miel con l-alanil-l-glutamina.
MX2015005733A (es) Compuestos triciclicos para usarse en el tratamiento y/o control de obesidad.
MX2013002261A (es) N-fenetiltriazolonacetamidas sustituidas y su uso.

Legal Events

Date Code Title Description
FG Grant or registration